Mark J. Foley - Dec 31, 2024 Form 4 Insider Report for Revance Therapeutics, Inc. (RVNC)

Role
CEO, Director
Signature
/s/ Dwight Moxie, Attorney-in-Fact
Stock symbol
RVNC
Transactions as of
Dec 31, 2024
Transactions value $
$2,185
Form type
4
Date filed
1/3/2025, 04:33 PM
Previous filing
Jul 2, 2024
Next filing
Feb 5, 2025
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction RVNC Common Stock Award $2.18K +1K +0.1% $2.18 997K Dec 31, 2024 Direct F1
holding RVNC Common Stock 111K Dec 31, 2024 See footnote F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These shares were acquired by Mr. Foley under the Issuer's 2014 Employee Stock Purchase Plan on December 31,2024 in a transaction that was exempt under both Rule 16b-3(d) and Rule 16b-3(c).
F2 These shares are held by the Mark and Dana Foley, Trustees, Foley Family Trust U/A DTD 4/10/2002.